{
  "id": [
    "32275914"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32275914"
  ],
  "pmcid": [
    "PMC7138382"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7138382"
      ]
    }
  ],
  "doi": [
    "10.1016/j.antiviral.2020.104791"
  ],
  "title": [
    "Type 1 interferons as a potential treatment against COVID-19."
  ],
  "authorString": [
    "Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Sallard E"
          ],
          "firstName": [
            "Erwan"
          ],
          "lastName": [
            "Sallard"
          ],
          "initials": [
            "E"
          ],
          "authorId": [
            {
              "_": "0000-0002-2324-3633",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "École Normale Supérieure de Paris, 45 Rue D'Ulm, 75005, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Lescure FX"
          ],
          "firstName": [
            "François-Xavier"
          ],
          "lastName": [
            "Lescure"
          ],
          "initials": [
            "FX"
          ],
          "authorId": [
            {
              "_": "0000-0002-2828-125X",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Yazdanpanah Y"
          ],
          "firstName": [
            "Yazdan"
          ],
          "lastName": [
            "Yazdanpanah"
          ],
          "initials": [
            "Y"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Mentre F"
          ],
          "firstName": [
            "France"
          ],
          "lastName": [
            "Mentre"
          ],
          "initials": [
            "F"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Université de Paris, IAME, INSERM, F-75018, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Peiffer-Smadja N"
          ],
          "firstName": [
            "Nathan"
          ],
          "lastName": [
            "Peiffer-Smadja"
          ],
          "initials": [
            "N"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Université de Paris, IAME, INSERM, F-75018, Paris, France; Department of Infectious and Tropical Diseases, Assistance Publique - Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France. Electronic address: nathan.peiffer-smadja@inserm.fr."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-2324-3633",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-2828-125X",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data",
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "178"
      ],
      "journalIssueId": [
        "2968204"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "Antiviral research"
          ],
          "ISOAbbreviation": [
            "Antiviral Res."
          ],
          "medlineAbbreviation": [
            "Antiviral Res"
          ],
          "NLMid": [
            "8109699"
          ],
          "ISSN": [
            "0166-3542"
          ],
          "ESSN": [
            "1872-9096"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "104791"
  ],
  "abstractText": [
    "Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19."
  ],
  "affiliation": [
    "École Normale Supérieure de Paris, 45 Rue D'Ulm, 75005, Paris, France."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "brief-report",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Interferon Type I"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antiviral Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IP"
                  ],
                  "qualifierName": [
                    "isolation & purification"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Interferon",
        "Covid-19",
        "Sars-cov-2"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antiviral Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Interferon Type I"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.antiviral.2020.104791"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7138382"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7138382?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "29"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCompletion": [
    "2020-07-06"
  ],
  "dateOfCreation": [
    "2020-04-11"
  ],
  "firstIndexDate": [
    "2020-04-12"
  ],
  "fullTextReceivedDate": [
    "2020-04-13"
  ],
  "dateOfRevision": [
    "2020-07-06"
  ],
  "electronicPublicationDate": [
    "2020-04-07"
  ],
  "firstPublicationDate": [
    "2020-04-07"
  ]
}